Pharmacology General 8ce106fb Crizotinib is used in the treatment of : A FLT-3 +ve Non small cell carcinoma of lung B ALK +ve Non small cell carcinoma of lung C FLT-3 +ve Acute myeloid leukemia D BRCA-2 +ve metastatic breast carcinoma High-Yield Explanation Crizotinib inhibits anaplastic lymphoma kinase (ALK), hence used in ALK mutation positive non small cell carcinoma of lungs.